2012
DOI: 10.1097/mpa.0b013e3182374f27
|View full text |Cite
|
Sign up to set email alerts
|

Safety and Accuracy of Percutaneous Core Needle Biopsy in Examining Pancreatic Neoplasms

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
6
0
2

Year Published

2013
2013
2019
2019

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 16 publications
(10 citation statements)
references
References 5 publications
2
6
0
2
Order By: Relevance
“…Several authors have evaluated the sensitivity and accuracy of pancreatic biopsy. The largest published series [33][34][35][36][37][38] reported sensitivity and accuracy of 86 -99.2 % and 86 -93 %, respectively, therefore comparable to those of FNA. It must be otherwise noted that the complication rate of biopsy reported in these studies was higher than that of FNA (3.3-21 %).…”
Section: Discussionsupporting
confidence: 57%
“…Several authors have evaluated the sensitivity and accuracy of pancreatic biopsy. The largest published series [33][34][35][36][37][38] reported sensitivity and accuracy of 86 -99.2 % and 86 -93 %, respectively, therefore comparable to those of FNA. It must be otherwise noted that the complication rate of biopsy reported in these studies was higher than that of FNA (3.3-21 %).…”
Section: Discussionsupporting
confidence: 57%
“…The sensitivity of US‐guided CNB has been reported to be 71% to 99% 13 15 . Previously estimated sensitivity and specificity of EUS‐guided FNA (75%–92% and 82%–100%, respectively) are comparable to the values in our study.…”
Section: Discussionsupporting
confidence: 87%
“…Previously estimated sensitivity and specificity of EUS‐guided FNA (75%–92% and 82%–100%, respectively) are comparable to the values in our study. Sensitivity values of EUS‐guided FNA and US‐guided CNB are reportedly lower in patients with chronic pancreatitis than in those without chronic pancreatitis 10 , 15 . Our study enrolled 10 patients with pancreatitis, which might have affected the sensitivity of both modalities.…”
Section: Discussionmentioning
confidence: 99%
“…A recent meta-analysis has shown that pooled sensitivity for malignant cytology was 85% and specificity was 98%, and if suspicious cytological results were included to determine true neoplasms, the sensitivity increased to 91%, but specificity dropped to 94% [7], whereas percutaneous CT-guided FNA of pancreatic lesions is normally used to simply confirm the diagnosis of malignancy before commencing palliative treatment [8]. The aim of the current study [1] was to "establish the feasibility of miRNA expression profiling of localised PDAC using material obtained from diagnostic FNA."…”
Section: Expert Commentary and Five-year Viewmentioning
confidence: 97%